DNA Based HPV Testing

In 2020, more than half a million women contracted cervical cancer, and about 342,000 women died as a result – most in the poorest countries. Quick and accurate screening programmes are critical so that every woman with cervical disease gets the treatment she needs, and avoidable deaths are prevented.

“Effective and accessible cervical screening and treatment programmes in every country are non-negotiable if we are going to end the unimaginable suffering caused by cervical cancer,” says Dr Princess Nono Simelela, Assistant Director-General for Strategic Programmatic Priorities: Cervical Cancer Elimination.

Dynamic Healthcare (Previously Dynamic Pharma) under Dynamic Group offers the leading HPV testing solution, with very fast turn around time, a simplified workflow and enables self sample collection or by medical professionals.

Contact us